Low-dose fludarabine plus cyclophosphamide is effective in patients with proliferative lupus nephritis, but is associated with considerable adverse outcomes

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1600, 2007-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract